117 related articles for article (PubMed ID: 6293593)
1. Subsensitivity of catecholaminergic neurons to direct acting agonists after single or repeated electroconvulsive shock.
Tepper JM; Nakamura S; Spanis CW; Squire LR; Young SJ; Groves PM
Biol Psychiatry; 1982 Oct; 17(10):1059-70. PubMed ID: 6293593
[TBL] [Abstract][Full Text] [Related]
2. Brain reinforcement mechanisms: alpha-adrenergic and dopaminergic agonists and antagonists.
Wauquier A; Clincke G; Fransen J
Prog Clin Biol Res; 1981; 71():177-96. PubMed ID: 7330078
[No Abstract] [Full Text] [Related]
3. Ethanol suppression of locus coeruleus neurons: relevancy to the fetal alcohol syndrome.
Strahlendorf HK; Strahlendorf JC
Neurobehav Toxicol Teratol; 1983; 5(2):221-4. PubMed ID: 6306495
[TBL] [Abstract][Full Text] [Related]
4. Lack of behavioral evidence for dopamine autoreceptor subsensitivity after acute electroconvulsive shock.
Creese I; Kuczenski R; Segal D
Pharmacol Biochem Behav; 1982 Aug; 17(2):375-6. PubMed ID: 6291070
[TBL] [Abstract][Full Text] [Related]
5. The neuroanatomy and pharmacology of the nucleus locus coeruleus.
Grant SJ; Redmond DE
Prog Clin Biol Res; 1981; 71():5-27. PubMed ID: 6276901
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological evaluation of a partial agonist of dopamine receptors.
Piercey MF; Hoffmann WE; Vogelsang GD; Travis M
J Pharmacol Exp Ther; 1987 Oct; 243(1):391-6. PubMed ID: 3668865
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
Huang KX; Walters JR
J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
[TBL] [Abstract][Full Text] [Related]
8. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording.
Grace AA; Bunney BS
J Pharmacol Exp Ther; 1986 Sep; 238(3):1092-100. PubMed ID: 3746660
[TBL] [Abstract][Full Text] [Related]
9. Intrasubthalamic injection of 6-hydroxydopamine induces changes in the firing rate and pattern of subthalamic nucleus neurons in the rat.
Ni Z; Bouali-Benazzouz R; Gao D; Benabid AL; Benazzouz A
Synapse; 2001 May; 40(2):145-53. PubMed ID: 11252026
[TBL] [Abstract][Full Text] [Related]
10. Actions of cocaine on central monoamine neurons: intracellular recordings in vitro.
Williams J; Lacey M
NIDA Res Monogr; 1988; 90():234-42. PubMed ID: 3151928
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: effects of subthalamotomy and levodopa treatment.
Bilbao G; Ruiz-Ortega JA; Miguens N; Ulibarri I; Linazasoro G; Gómez-Urquijo S; Garibi J; Ugedo L
Brain Res; 2006 Apr; 1084(1):175-84. PubMed ID: 16574080
[TBL] [Abstract][Full Text] [Related]
12. Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission.
Dorr AE; Debonnel G
J Pharmacol Exp Ther; 2006 Aug; 318(2):890-8. PubMed ID: 16690723
[TBL] [Abstract][Full Text] [Related]
13. Correlation between the inhibitory effect on catecholaminergic ventrolateral medullary neurons and the hypotension evoked by clonidine: a voltammetric approach.
Tibirica E; Mermet C; Feldman J; Gonon F; Bousquet P
J Pharmacol Exp Ther; 1989 Aug; 250(2):642-7. PubMed ID: 2760846
[TBL] [Abstract][Full Text] [Related]
14. Clonidine fails to modify dopaminergic neuronal activity during morphine withdrawal.
Gobbi G; Muntoni AL; Gessa GL; Diana M
Psychopharmacology (Berl); 2001 Oct; 158(1):1-6. PubMed ID: 11685378
[TBL] [Abstract][Full Text] [Related]
15. Receptor reserve and turnover of alpha-2 adrenoceptors that mediate the clonidine-induced inhibition of rat locus coeruleus neurons in vivo.
Pineda J; Ruiz-Ortega JA; Ugedo L
J Pharmacol Exp Ther; 1997 May; 281(2):690-8. PubMed ID: 9152374
[TBL] [Abstract][Full Text] [Related]
16. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of striatal drug infusions.
Tepper JM; Nakamura S; Young SJ; Groves PM
Brain Res; 1984 Sep; 309(2):317-33. PubMed ID: 6089960
[TBL] [Abstract][Full Text] [Related]
17. Effects of crus cerebri lesions and repeated amphetamine treatment on the activity of nigral dopaminergic neurons.
Heidenreich BA; Rebec GV
Synapse; 2000 Oct; 38(1):80-6. PubMed ID: 10941143
[TBL] [Abstract][Full Text] [Related]
18. U-66444B and U-68553B, potent autoreceptor agonists at dopaminergic cell bodies and terminals.
Piercey MF; Broderick PA; Hoffmann WE; Vogelsang GD
J Pharmacol Exp Ther; 1990 Aug; 254(2):369-74. PubMed ID: 1974631
[TBL] [Abstract][Full Text] [Related]
19. Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors.
Pucak ML; Grace AA
J Pharmacol Exp Ther; 1994 Dec; 271(3):1181-92. PubMed ID: 7996424
[TBL] [Abstract][Full Text] [Related]
20. A role of some central neurotransmitter systems in the mechanism of electroconvulsive shock action.
Kleinrok Z; Wielosz M
Pol J Pharmacol Pharm; 1985; 37(6):745-52. PubMed ID: 3008135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
